Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Singular Genomics Systems to related companies based on the strength of its analyst recommendations, valuation, earnings, profitability, institutional ownership, dividends and risk. Institutional & […]